BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 1602514)

  • 1. The endocrinology and pathophysiology of alcoholic cirrhosis and functional renal failure--a review.
    Domurat ES; Elias AN
    J Natl Med Assoc; 1992 Feb; 84(2):153-62. PubMed ID: 1602514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathophysiology of ascites and functional renal failure in cirrhosis.
    Arroyo V; Bernardi M; Epstein M; Henriksen JH; Schrier RW; Rodés J
    J Hepatol; 1988 Apr; 6(2):239-57. PubMed ID: 3045195
    [No Abstract]   [Full Text] [Related]  

  • 3. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
    Ginès P; Arroyo V; Rodés J
    Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
    [No Abstract]   [Full Text] [Related]  

  • 4. [Acute kidney insufficiency in an alcoholic patient with liver cirrhosis].
    Räz HR; Moch H; Wagner P
    Schweiz Med Wochenschr; 1996 Jul; 126(30):1306-13. PubMed ID: 8765771
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.
    Arroyo V; Ginès P; Gerbes AL; Dudley FJ; Gentilini P; Laffi G; Reynolds TB; Ring-Larsen H; Schölmerich J
    Hepatology; 1996 Jan; 23(1):164-76. PubMed ID: 8550036
    [No Abstract]   [Full Text] [Related]  

  • 6. LEFT ventricular function assessed by echocardiography in cirrhosis: relationship to systemic hemodynamics and renal dysfunction.
    Nazar A; Guevara M; Sitges M; Terra C; Solà E; Guigou C; Arroyo V; Ginès P
    J Hepatol; 2013 Jan; 58(1):51-7. PubMed ID: 22989573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pathogenesis and management of hepatorenal syndrome in patients with cirrhosis.
    Angeli P; Merkel C
    J Hepatol; 2008; 48 Suppl 1():S93-103. PubMed ID: 18304678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fluid retention in cirrhosis: pathophysiology and management.
    Kashani A; Landaverde C; Medici V; Rossaro L
    QJM; 2008 Feb; 101(2):71-85. PubMed ID: 18184668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathogenesis of ascites in cirrhosis and portal hypertension.
    Heneghan MA; Harrison PM
    Med Sci Monit; 2000; 6(4):807-16. PubMed ID: 11208415
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.
    Gentilini P; Laffi G; La Villa G; Raggi VC
    Ann Ital Med Int; 1999; 14(4):264-84. PubMed ID: 10638019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatorenal syndrome.
    Bataller R; Arroyo V; Ginès P; Sort P
    Forum (Genova); 1998; 8(1):62-81. PubMed ID: 9565447
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascites and hepatorenal syndrome.
    Gentilini P; Vizzutti F; Gentilini A; La Villa G
    Eur J Gastroenterol Hepatol; 2001 Apr; 13(4):313-6. PubMed ID: 11338056
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ascites and hepatorenal syndrome during cirrhosis: two entities or the continuation of the same complication?
    Gentilini P; Laffi G; La Villa G; Romanelli RG; Blendis LM
    J Hepatol; 1999 Dec; 31(6):1088-97. PubMed ID: 10604585
    [No Abstract]   [Full Text] [Related]  

  • 14. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
    Wong F; Pantea L; Sniderman K
    Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hepatorenal syndrome].
    Mijac D; Kezić A; Stojimirović B
    Srp Arh Celok Lek; 2007; 135(1-2):98-104. PubMed ID: 17503577
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal and circulatory dysfunction in cirrhosis: current management and future perspectives.
    Solà E; Ginès P
    J Hepatol; 2010 Dec; 53(6):1135-45. PubMed ID: 20850887
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Calcitonin gene-related peptide in hepatorenal syndrome. A possible mediator of peripheral vasodilation?
    Gupta S; Morgan TR; Gordan GS
    J Clin Gastroenterol; 1992 Mar; 14(2):122-6. PubMed ID: 1532610
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].
    Ackermann D
    Ther Umsch; 2009 Nov; 66(11):747-51. PubMed ID: 19885792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Autonomic dysfunction in alcoholic cirrhosis: relationship to indicators of synthetic activation and the occurrence of renal sodium retention.
    Lewis FW; Cohen JA; Rector WG
    Am J Gastroenterol; 1991 May; 86(5):553-9. PubMed ID: 2028944
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Hepatorenal syndrome: pathogenesis and treatment].
    Ashkenazi E; Ilan Y; Shoval D
    Harefuah; 2007 Jun; 146(6):475-9, 499. PubMed ID: 17760404
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.